logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Carlotta Antoniotti

azienda ospedaliero-universitaria pisana
H指数:34
被引数:7,817

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO

帕尼单抗（panitumumab）再治疗随后使用瑞戈非尼（regorafenib）与相反顺序在RAS和 BRAF野生型循环肿瘤DNA的化学耐药性转移性结直肠癌患者中的比较：GONO进行的PARERE研究

Annals of Oncology
IF65.4
2025-10-180
OAAI
P. Ciracì; M.M. Germani; F. Pietrantonio; P. Manca; S. Lonardi; A. Busico; F. Bergamo; V. Burgio; F. Mannavola; S. Di Donato; E. Fenocchio; F. Palermo; I. Capone; M.C. De Grandis; N. Pella; M. Scartozzi; L. Antonuzzo; A. Passardi; M. Claravezza; L. Salvatore; S. Tamberi; G. Randon; E. Conca; V. Conca; C. Antoniotti; R. Moretto; G. Masi; L. Boni; D. Rossini; C. Cremolini
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: an individual patient data-based pooled analysis of randomized trials

FOLFOXIRI/bevacizumab与双药/bevacizumab作为不可切除的肝-only、右侧和/或RAS或BRAF突变转移性结直肠癌初始治疗的比较：一项基于个体患者数据的随机试验合并分析

European Journal of Cancer
IF7.1
2025-08-150
PRE
Carlotta Antoniotti; Federica Marmorino; Daniele Rossini; Hans Joachim Schmoll; Sara Lonardi; Giuseppe Tonini; Beatrice Borelli; Samanta Cupini; Alexander Stein; Roberto Moretto; Francesca Bergamo; Monica Ronzoni; Marco Maria Germani; Alberto Zaniboni; Roberta Fazio; Maria Caterina De Grandis; Elena Ongaro; Gianluca Masi; Chiara Cremolini
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies

FOLFOXIRI和FOLFOX/FOLFIRI两种一线方案，无论是否联合贝伐珠单抗，其相对剂量强度均会影响转移性结直肠癌患者的预后：TRIBE和TRIBE2研究的合并分析

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-06-010
PRE
Moretto, R.; Rossini, D.; Polito, Mariam Grazia; Antoniotti, Carlotta; Intini, Rossana; Conca, Veronica; Andena, Paola; Carullo, Martina; Salvatore, Lisa; Germani, Marco Maria; Bergamo, Francesca; Passardi, Alessandro; Ciraci, Paolo; Tamburini, Emiliano; Boccaccio, Chiara; Zaniboni, Alberto; Masi, Gianluca; Pietrantonio, Filippo; Lonardi, Sara; Cremolini, C.
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAFV600E-mutated metastatic colorectal cancer treated with targeted therapy
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-01-070
OAAI
Vetere, Guglielmo; Germani, Marco Maria; Antoniotti, Carlotta; Salvatore, Lisa; Pietrantonio, Filippo; Lonardi, Sara; Bensi, Maria; Ghelardi, Filippo; Calegari, Maria Alessandra; Intini, Rossana; Minelli, Alessandro; Sullo, Francesco Giulio; Boccaccio, Chiara; Taravella, Ada; Puccini, Alberto; Lavacchi, Daniele; Noto, Laura; Salati, Massimiliano; Scartozzi, Mario; Cremolini, Chiara
Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO

评估不可切除的转移性结直肠癌一线治疗中疾病进展风险的评估，以指导放射学评估的间隔：AIO和GONO进行的十一项随机试验的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Germani, M. M.; Heinemann, V.; Rossini, D.; von Weikersthal, L. Fischer; Morano, F.; Heinrich, K.; Stahler, A.; Bergamo, F.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; Russo, A.; Fuchs, M.; Prete, A. A.; Antoniotti, C.; Masi, G.; Stintzing, S.; Cremolini, C.; Modest, D. P.
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-12-012
OA
Pietrantonio, Filippo; Bergamo, Francesca; Rossini, Daniele; Ghelardi, Filippo; De Grandis, Maria Caterina; Germani, Marco Maria; Barsotti, Giulia; Formica, Vincenzo; Frassineti, Giovanni Luca; Boscolo, Giorgia; Cinieri, Saverio; Di Donato, Samantha; Antonuzzo, Lorenzo; Antoniotti, Carlotta; Ambrosini, Margherita; Piva, Vittoria Matilde; Nichetti, Federico; Fassan, Matteo; Cremolini, Chiara; Lonardi, Sara
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
CLINICAL COLORECTAL CANCER
IF3.2
2023-09-010
PRE
Borelli, Beatrice; Conca, Veronica; Carullo, Martina; Sainato, Aldo; Mattioni, Roberto; Manfredi, Bruno; Balestri, Riccardo; Buccianti, Piero; Morelli, Luca; Rossi, Piercarlo; Vagli, Paola; Prete, Alessandra Anna; Luca, Frassineti; Morano, Federica; Di Donato, Samantha; Salvatore, Lisa; Bengala, Carmelo; Rossini, Daniele; Boni, Luca; Antoniotti, Carlotta; Masi, Gianluca; Cremolini, Chiara; Moretto, Roberto
Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study
ANNALS OF ONCOLOGY
IF65.4
2023-06-010
OA
Marmorino, F.; Piccinno, G.; Rossini, D.; Ghelardi, F.; Murgioni, S.; Salvatore, L.; Nasca, V.; Antoniotti, C.; Daniel, F.; Schietroma, F.; Conca, V.; Silva, C. Alves Costa; Tamburini, E.; Tamberi, S.; Passardi, A.; Carullo, M.; Antonuzzo, L.; D'Onofrio, R.; Zitvogel, L.; Cremolini, C.; Derosa, L.
Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAFV600E mutated (mut) metastatic colorectal cancer (mCRC) receiving targeted therapy (TT) as second-line treatment
ANNALS OF ONCOLOGY
IF65.4
2023-06-010
OAAI
Vetere, G.; Germani, M.; Bensi, M.; Antoniotti, C.; Lonardi, S.; Passardi, A.; Ghelardi, F.; Calegari, M.; Borelli, B.; Santucci, S.; Intini, R.; Cristarella, E.; Persano, M.; Puccini, A.; Lavacchi, D.; Noto, L.; Zichi, C.; Giampieri, R.; Salati, M.; Cremolini, C.

研究方向

暂未获取到该数据
C
Chiara Cremolini
H 指数:65论文数:976被引数:2.0万
S
Sara Lonardi
H 指数:83论文数:1,229被引数:3.4万
F
Filippo Pietrantonio
H 指数:61论文数:1,034被引数:1.6万
A
Alfredo Falcone
H 指数:89论文数:1,289被引数:4.1万
G
Gianluca Masi
H 指数:58论文数:574被引数:2.0万
D
Daniele Rossini
H 指数:30论文数:219被引数:3,661
R
Roberto Moretto
H 指数:28论文数:188被引数:3,213
F
Federica Marmorino
H 指数:30论文数:186被引数:3,601
F
Francesca Bergamo
H 指数:47论文数:565被引数:8,932
B
Beatrice Borelli
H 指数:22论文数:112被引数:2,123